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Abstract Myelin, made by oligodendrocytes, is essential for rapid information transfer in the
central nervous system. Oligodendrocyte precursors (OPs) receive glutamatergic synaptic input
from axons but how this affects their development is unclear. Murine OPs in white matter express
AMPA receptor (AMPAR) subunits GluA2, GluA3 and GluA4. We generated mice in which OPs lack
both GluA2 and GluA3, or all three subunits GluA2/3/4, which respectively reduced or abolished
AMPAR-mediated input to OPs. In both double- and triple-knockouts OP proliferation and number
were unchanged but ~25% fewer oligodendrocytes survived in the subcortical white matter during
development. In triple knockouts, this shortfall persisted into adulthood. The oligodendrocyte
deficit resulted in ~20% fewer myelin sheaths but the average length, number and thickness of
myelin internodes made by individual oligodendrocytes appeared normal. Thus, AMPAR-mediated
signalling from active axons stimulates myelin production in developing white matter by enhancing
oligodendrocyte survival, without influencing myelin synthesis per se.
DOI: 10.7554/eLife.28080.001
Introduction
Myelination of axons by oligodendrocytes (OLs), which develop postnatally from proliferating oligo-
dendrocyte precursors (OPs), enables fast and energy-efficient propagation of electrical signals in
the central nervous system (CNS). By decreasing the capacitance of axons, myelin dramatically
increases the speed of action potentials and reduces the energy demands of the axons. Moreover,
the ensheathing OLs can transfer energy substrates into axons (Fu¨nfschilling et al., 2012; Lee et al.,
2012b; Saab et al., 2016) possibly supporting them during periods of high metabolic demand. Syn-
thesis of myelin requires a large investment of energy (Harris and Attwell, 2012), so it seems likely
that myelination evolved to focus on active axons, rather than axons that are electrically silent
because, for example, they are still elongating, or they are excess to requirements and destined for
developmental pruning. This would require that developing OLs can sense the electrical activity of
axons.
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OLs that differentiate in culture from purified OPs can myelinate fixed axons and synthetic nanofi-
bres in vitro, so electrically active axons are not essential for myelination (Rosenberg et al., 2008;
Lee et al., 2012a; Bechler et al., 2015). Nevertheless, many in vitro and in vivo studies suggest that
electrical activity can modulate myelination by influencing the proliferation and/or differentiation of
OPs, thus determining the number of OLs that are available to myelinate (Barres and Raff, 1993;
Demerens et al., 1996; Li et al., 2010; Gibson et al., 2014; Fannon et al., 2015; Etxeberria et al.,
2016). In addition, electrical activity can influence the process of myelination by OLs (Hines et al.,
2015; Mensch et al., 2015; Wake et al., 2011; Lundgaard et al., 2013; Wake et al., 2015;
Etxeberria et al., 2016). OL production and myelination in juvenile or adult mice are also influenced
by experience, presumably via altered neuronal activity (Simon et al., 2011; Liu et al., 2012;
Makinodan et al., 2012; Mangin et al., 2012; Sampaio-Baptista et al., 2013; Hill et al., 2014;
McKenzie et al., 2014; Xiao et al., 2016).
How might electrical activity be signalled to OL lineage cells? A likely mechanism is that neuro-
transmitters released from active axons modulate OL formation or myelination. OL lineage cells can
sense the release of neurotransmitter directly, because they express ligand-gated channels
(reviewed by Larson et al., 2016), including AMPA/kainate and NMDA receptors for the excitatory
transmitter glutamate. OPs receive direct AMPA receptor (AMPAR)-mediated synaptic input from
unmyelinated or partially myelinated axons in all brains regions examined so far (Bergles et al.,
2000; Chittajallu et al., 2004; Lin and Bergles, 2004; Lin et al., 2005; Ge et al., 2006;
Kukley et al., 2007; Ziskin et al., 2007; Ka´rado´ttir et al., 2008; Mu¨ller et al., 2009). Synaptic input
is maintained during OP division (Kukley et al., 2008; Ge et al., 2009) but is down-regulated as
OPs differentiate into OLs (Cahoy et al., 2008; De Biase et al., 2010; Kukley et al., 2010), suggest-
ing that it might be important in the control of OL development.
In support of the idea that neurotransmitters regulate myelination, blocking vesicular release
from neurons in vitro (Wake et al., 2011, 2015) or in genetically manipulated zebrafish (Hines et al.,
2015; Mensch et al., 2015; Koudelka et al., 2016) reduced myelination without much affecting OL
numbers. Conversely, blocking glutamate uptake into secretory vesicles in retinal ganglion cells in
early postnatal mice increased the number of OLs that developed in the optic tract, suggesting that
glutamate signalling negatively regulates OL development (Etxeberria et al., 2016). Glutamate-
evoked NMDA receptor (NMDAR)-mediated signalling in OL lineage cells has been suggested to
accelerate the myelination of active axons (Lundgaard et al., 2013), which might occur by NMDAR
activation up-regulating glucose transport into developing OLs (Saab et al., 2016). The role of syn-
aptic AMPAR signalling is more enigmatic; pharmacological block of AMPAR-mediated signalling in
OPs in vitro promotes proliferation and differentiation of OPs (Gallo et al., 1996; Yuan et al., 1998;
Fannon et al., 2015) but decreases myelination (Fannon et al., 2015). These data are hard to inter-
pret, because pharmacological manipulations of AMPARs in vitro affect not only OPs but also neu-
rons, which might release substances other than glutamate to regulate myelination. Hence, we still
do not have direct in vivo evidence for a role of AMPAR signalling in regulating OL lineage
development.
To identify effects on myelination of AMPAR signalling in OL lineage cells, it is necessary to
manipulate AMPARs in those cells without affecting neuronal AMPARs. We have therefore used
Sox10-Cre to inactivate the Gria2 gene (encoding AMPAR subunit GluA2), or both Gria2 and Gria4,
specifically in OL lineage cells on a Gria3 germline knockout background. Examination of these
Gria2/3 and Gria2/3/4 compound mutant mice revealed that AMPAR signalling in OPs promotes the
development of OLs and myelin sheaths by stimulating survival of newly-differentiating OLs.
Results
OPs in subcortical white matter express AMPAR subunits GluA2-4 but
not GluA1
To determine which AMPAR subunits are expressed by OPs in vivo, we examined sections of postna-
tal mouse forebrain by in situ hybridization (ISH) for Gria1-4, which encode receptor subunits GluA1-
4 (also known as GluR1-4 or GluRA-D). We focused on subcortical white matter (SCWM), which con-
tains axons, glial cells and blood vessels but very few neuronal cell bodies. We found that Gria2,
Gria3 and Gria4 are expressed by many small cells in the postnatal day 1 (P1) and P14 SCWM
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(Figure 1). In contrast, Gria1 was expressed by very few cells in the SCWM, which NeuN labelling
showed were neurons (Figure 1A–C and not shown). As expected, Gria1-4 were all expressed highly
by many neurons throughout the forebrain (Figure 1A). Fluorescence ISH for individual Gria family
members followed by immunolabelling for the transcription factor Olig2 confirmed that Gria2-4
were expressed by OL lineage cells in white matter; Olig2 was expressed in 88 ± 3% of Gria2+ cells
(817 cells counted in four mice), 94 ± 4% of Gria3+ cells (506 cells from three mice) and 90 ± 0.3% of
Gria4+ cells (560 cells from three mice) (Figure 2A–C). Double ISH for Pdgfra and Gria2 followed by
immunolabelling for Olig2 indicated that GluA2 is expressed by the majority of OPs (Figure 2D),
consistent with previous electrophysiological findings (Kukley et al., 2007; Ziskin et al., 2007).
Occasional large cells with strong Gria expression but no Olig2 co-labelling (Figure 2B) were shown
to be white matter neurons (NeuN+, not shown). Together, these data indicate that GluA2-4 are the
main AMPAR subunits expressed by OL lineage cells in the developing mouse SCWM.
Gria3 germline knockout (KO) mice have no overt neural phenotype (Meng et al., 2003). Gria2
germline KOs have higher than normal mortality; the survivors are anatomically normal but display a
range of behavioural abnormalities, including reduced exploratory and reproductive activity and
impaired motor coordination (Jia et al., 1996; Gerlai et al., 1998; Jia et al., 2001; Shimshek et al.,
2006a). Gria2/3 double KOs were reported also to develop tremor, starting in the second postnatal
week (Meng et al., 2003). Since tremor is a hallmark of dysmyelination this suggested to us that
impaired AMPAR signalling in OL lineage cells might inhibit normal myelin development. We
Figure 1. GluA2–4, but not GluA1 are expressed by presumptive OL lineage cells in the corpus callosum. (A) Low-magnification images of Gria1 and
Gria2 ISH at P14. The corpus callosum (rectangles) is shown at higher magnification for Gria1-4 (left to right) at P1 (B) and P14 (C). Gria2, Gria3 and
Gria4 are expressed in many cells with small cell bodies - putative OL lineage cells - in the corpus callosum. The few Gria1-positive cells visible in white
matter are misplaced neurons (NeuN-positive, not shown). Many forebrain neurons in grey matter strongly express Gria1-4. Scale bars: (A) 400 mm, (B–
C) 50 mm.
DOI: 10.7554/eLife.28080.002
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Figure 2. Gria2-4 are expressed in OL lineage cells. (A–C) Fluorescence ISH for Gria2-4 followed by immunohistochemistry for Olig2 in P14 corpus
callosum indicates that Gria2-4 are expressed in OL lineage cells (arrows). Occasional Gria+ Olig2– cells (e.g. arrowhead in middle row) are presumptive
neurons. (D) Double fluorescence ISH for Gria2 and Pdgfra followed by immunolabelling for Olig2, P9 corpus callosum. All Gria2+ cells are Olig2+ OL
lineage cells. Many of these are (Gria2+, Pdgfra+, Olig2+) OPs. Some (Gria2–, Pdgfra+) cells (arrowhead) and (Gria2+, Pdgfra–, Olig2+) cells (arrow) are
Figure 2 continued on next page
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decided to test this directly by inactivating both Gria2 and Gria3 in OL lineage cells. Before attempt-
ing this we checked whether deleting either subunit on its own affects OL development.
GluA2 and GluA3 are individually dispensable for OL production
Gria3 is X-linked in mice. To check whether Gria3null mice (i.e. Gria3–/Y males or Gria3–/– females)
exhibit any obvious OL lineage-related defects, we immunolabelled P14 and P21 forebrain sections
with anti-Pdgfra to detect OPs or with monoclonal CC1 (anti-adenomatous polyposis coli, APC) for
differentiated OLs. The density (cells per mm2) of Pdgfra+ OPs in the SCWM was unaltered in
Gria3null mice compared to wild type littermates at both ages (p=0.66 at P14; p=0.7 at P21, Mann-
Whitney test; Figure 3A,D) and there was no change in the density of CC1+ OLs (p=0.66 at P14;
p=0.7 at P21, Mann-Whitney test; Figure 3B,E). We examined the proliferation rate of OPs by
administering 5’-ethynyl-2’-deoxyuridine (EdU) for 8 hr on P14. There was no significant difference in
the fraction of Pdgfra+ OPs that incorporated EdU in Gria3null mice versus wild type controls
(p=0.66, Mann-Whitney test; Figure 3C,F), indicating that the proliferation rate of OPs was not
affected by loss of GluA3. We also counted the density of myelinated axons as well as their g-ratios
in parasagittal sections of anterior SCWM in electron micrographs and found no difference between
Gria3null mice and wild type controls at P14 (p=0.4, Mann-Whitney test; Figure 3G,H). Furthermore,
there was no change in the frequency distribution of either myelinated or unmyelinated axon diame-
ters (Figure 3I,J). Therefore, loss of GluA3 alone does not detectably affect postnatal OL production
or myelination.
The GluA2 subunit is functionally distinct from other AMPAR subunits because its mRNA can be
edited to change a glutamine (Q) codon to an arginine (R) codon, causing AMPAR tetramers that
contain the edited ‘R’ version to be Ca2+ – impermeable. To investigate the role of GluA2 in OL
development we generated conditional knockouts (cKOs) by crossing Sox10-Cre (Matsuoka et al.,
2005) to Gria2flox/flox mice, in which exon 11 of Gria2 is flanked by loxP sites (Shimshek et al.,
2006b), on the Rosa-YFP reporter background (Srinivas et al., 2001). In the CNS, Sox10 expression
is restricted to OL lineage cells – OPs in the embryo and both OPs and OLs postnatally (Stolt et al.,
2002). The above cross generated Sox10-Cre: Gria2flox/flox cKOs alongside Sox10-Cre: Gria2flox/+
and Sox10-Cre: Gria2+/+ littermate controls (all including Rosa-YFP) (Figure 4—figure supplement
1A). We refer to these as Gria2–/–, Gria2+/– and Gria2+/+. Most OPs (~80%) in the postnatal SCWM
of wild type mice originate after birth (E21/P0) from neural stem cells in the cortical ventricular zone
(VZ), with the remaining ~20% of OPs migrating into the developing cortex from the ventral fore-
brain starting around embryonic day 16 (E16) (Kessaris et al., 2006; Tripathi et al., 2011; reviewed
by Bergles and Richardson, 2015). Thus, Sox10-Cre driven recombination at the Gria2flox locus is
expected to commence in the cortex and SCWM before birth and to continue after birth.
Control Sox10-Cre: Rosa-YFP mice (without Gria2flox) displayed widespread expression of the
YFP reporter (Figure 4—figure supplement 2). In the SCWM at P14, 96.4% ± 1.0% of Sox10+ cells
expressed YFP (5551 cells counted in four mice; Figure 4—figure supplement 2A). In the cortex,
97.1 ± 0.7% of Sox10+ cells expressed YFP (2506 Sox10+ cells counted in four mice; Supplementary
Figure 4—figure supplement 2B), confirming that Cre was active in the great majority of OL lineage
cells in both grey and white matter. YFP expression was restricted to Sox10+ cells in SCWM (98.1 ±
0.5% of YFP+ cells were Sox10+) and was also predominantly in Sox10+ cells in cortical grey matter
(88.1 ± 1.6% of YFP+ cells were Sox10+; Figure 4—figure supplement 2). YFP expression was also
observed in some astrocytes and neurons (NeuN+) in the ventral forebrain and in a small fraction of
cortical projection neurons (1.5 ± 0.4%; 9894 NeuN+ neurons counted in three animals; Figure 4—
figure supplement 2B) as well as some astrocytes (not quantified).
To confirm that GluA2 was deleted in Gria2–/– OPs, fluorescence-guided whole cell patch-clamp
recordings from YFP+ OPs in the SCWM of P14 mice were compared to age-matched controls.
AMPAR tetramers lacking GluA2 display inwardly-rectifying current responses to kainate and AMPA,
due to a voltage-dependent block of the channel by polyamines at positive potentials (Donevan and
Figure 2 continued
also present, suggesting that not all OPs express detectable levels of Gria2 and that some differentiating OLs (Pdgfra–, Olig2+) continue to express
Gria2. Scale bars: (A–C) 50 mm, (D) 25 mm.
DOI: 10.7554/eLife.28080.003
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Figure 3. Gria3 germline KO mice generate normal numbers of OPs and OLs. (A, B) Immunolabelling for Pdgfra+ OPs (A) or CC1+ OLs (B) in P14
corpus callosum of wild type (WT) and Gria3null mice. (C) EdU was administered to P14 wild type and Gria3null mice for 8 hr before analyzing the corpus
callosum by Pdgfra immunolabelling and EdU detection. (D, E) Cell counts reveal no difference in the density of OPs at P14 and P21 (D; p=0.66 at P14,
p=0.7 at P21, Mann-Whitney test; >600 cells counted in each mouse) or OLs (E; p=0.66 at P14, p=0.7 at P21, Mann-Whitney test; >900 cells counted in
Figure 3 continued on next page
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Rogawski, 1995). When GluA2 is present (in the edited ‘R’ form), the current-voltage (I-V) relation-
ship is linear, that is, non-rectifying. Application of kainate (100 mM), which activates AMPA and kai-
nate receptors, elicited an inward current at negative potentials in all OPs examined (Figure 4A).
The I-V relationship of the kainate-evoked current in the presence in the patch pipette of spermine
(100 mM), a polyamine that reduces outward current flow in AMPARs that lack GluA2, appeared
inwardly-rectifying in all cells examined from Gria2–/– brain slices but was almost linear in Gria2+/–
and Gria2+/+ controls (Figure 4B,C). The rectification index (RI), defined as (kainate-mediated cur-
rent amplitude at +17 mV)/ (current amplitude at –63 mV), was significantly reduced in Gria2–/– mice
compared to Gria2+/– and Gria2+/+ (p<10–4, one-way ANOVA with Bonferroni post-hoc test;
Figure 4D), confirming that GluA2 had been successfully deleted. Despite this, the kainate-evoked
current density (current normalized to membrane capacitance, which is proportional to cell surface
area) at –63 mV in Gria2–/– OPs was not significantly reduced compared to Gria2+/– or Gria2+/+
(p=0.73, Kruskal-Wallis test; Figure 4E). Thus, activation of AMPARs present at the cell surface in
the presence or absence of GluA2 generates the same membrane current at –63 mV, presumably as
a result of compensation from other AMPAR subunits, but the voltage-dependence of the current is
different in Gria2–/– mice (Figure 4C).
The density (cells per mm2) of Pdgfra+ OPs in SCWM was unaltered in Gria2–/– mice compared to
Gria2+/+ controls at P14 (p=0.34, Mann-Whitney test; Figure 4F,H), as was the density of CC1+ cells
(p=0.40, Mann-Whitney test; Figure 4F,H). To test whether the OP proliferation rate was altered we
administered EdU to P14 Gria2–/– and Gria2+/- mice (Figure 4G,I). There was no significant differ-
ence between the EdU labelling indices of Pdgfra+ OPs in Gria2–/– versus Gria2+/– (p=0.94, Mann-
Whitney test), indicating that the cell cycle time of OPs was not affected (Figure 4G,I). These results
demonstrate that OL development is normal in the absence of GluA2, despite the altered AMPAR
Ca2+ permeability.
Double deletion of GluA2/ GluA3 in the OL lineage
To generate mice in which OL lineage cells lack both GluA2 and GluA3, we deleted Gria2flox condi-
tionally, using Sox10-Cre, in the Gria3 germline KO background. We chose this approach rather than
attempting a double Gria2/Gria3 cKO because it simplifies the breeding program and it might
increase the probability of Cre-mediated deletion at both Gria2flox/flox alleles, by eliminating poten-
tial competition with Gria3flox.
By appropriate breeding (Figure 4—figure supplement 1B) we generated mice with the geno-
type Sox10-Cre: Gria3null: Gria2flox/flox: Rosa–YFP (referred to as Gria3null2–/–). Control mice were
Gria3null with two functional copies of Gria2, either because they carried wild type alleles of Gria2
(no loxP sites) or because they did not carry the Sox10-Cre transgene. In some experiments, mice
with one functional copy of Gria2 were also used as controls (Figure 4—figure supplement 1B). We
designate these controls Gria3null2+/+ and Gria3null2+/–, respectively. As observed for Gria2–/– (see
above), the kainate-evoked current in Gria3null2–/– was inwardly-rectifying in all YFP+ OPs that we
examined, whereas Gria3null2+/+ and Gria3null2+/– controls had an almost linear I-V relationship (Fig-
ure 5—figure supplement 1A). The rectification index was significantly reduced in Gria3null2–/– mice
compared to Gria3null2+/– and Gria3null2+/+ controls (p<10 4, Kruskal-Wallis with Dunn’s post-hoc
test; Figure 5—figure supplement 1B). These data confirm that, as for Gria2–/– single cKOs, our
genetic strategy had deleted GluA2 efficiently in OPs of Gria3null2–/– mice.
Figure 3 continued
each mouse) in Gria3null versus WT corpus callosum. (F) Cell counts reveal no difference between the EdU labelling indices of Pdgfra+ OPs in WT versus
Grianull corpus callosum (p=0.66, Mann-Whitney test). (G) There was no change in the number of cross-sectional myelin figures per unit area in P14
Gria3null compared to WT littermate controls (p=0.4, Mann-Whitney test). (H) Scatter plot of g-ratios as a function of axon diameter in P14 Gria3null and
wild type mice (>130 axons measured in each of three mice per group). (I) Frequency distribution of myelinated axon diameters from P14 Gria3null and
WT mice (>800 axons measured in each of three mice per group). (J) Frequency distribution of unmyelinated axon diameters from P14 Gria3null and WT
mice (>800 axons measured in each of three mice per group). Numbers of mice analyzed are indicated in (D), (E) and (F). Scale bar: 50 mm.
DOI: 10.7554/eLife.28080.004
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Figure 4. Gria2 knock-out renders AMPARs in OPs inwardly-rectifying but does not alter numbers of OL lineage cells in white matter. (A) Patch-
clamp recording of an OP in SCWM in an acute slice of wild type mouse forebrain, showing inward current generated by bath application of 100 mM
kainate. (B) Currents evoked by voltage steps from –63 mV in Gria3null2+/+ OP before (control) and during application of 100 mM kainate. Voltage steps
were in 20 mV increments from –103 mV to +17 mV. (C) Current-voltage (I–V) plots of kainate-evoked current in OPs of P14 Gria2-/– mice and
Figure 4 continued on next page
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AMPAR-mediated currents are reduced in Gria3null2–/– OPs
Gria3null2–/– mice were viable and survived into adulthood without neurological signs, suggesting
that the tremor reported in Gria2/3 germline KO mice (Meng et al., 2003) was not related to
impaired AMPAR signalling in OL lineage cells. Since Gria3null2–/– OPs lack both GluA2 and GluA3,
and GluA1 appears not to be expressed in the SCWM of wild type mice (see above, first paragraph
of Results; Figure 1), this implies that Gria3null2–/– OPs express GluA4 alone. Thus, it might be
expected that fewer AMPARs would be assembled in OPs from Gria3null2–/– mice relative to
controls.
To test this, we whole-cell patch-clamped YFP+ OPs in the SCWM of P14 Gria3null2–/– and
Gria3null2+/+ mice and measured kainate-evoked currents at –63 mV. In both genotypes, bath appli-
cation of 100 mM kainate elicited inward currents, indicating that AMPA/kainate receptors were pres-
ent (Figure 5A). Normalizing the amplitude of the maximum kainate-evoked current at –63 mV to
the cell size (assessed as membrane capacitance) revealed a significant (~47%) reduction in the cur-
rent density for Gria3null2–/– compared to Gria3null2+/+ controls (p<10–4, Student’s t-test; Figure 5B),
indicating that the number of AMPARs expressed on the cell surface was decreased in Gria3null2–/–
mice. The alternative explanation, that the single-channel current passed by the remaining AMPARs
was reduced, is less likely because GluA4 homo-tetramers are reported to have a higher conduc-
tance than GluA2/GluA4 hetero-dimers, for example (Swanson et al., 1997).
Application of kainate activates both AMPA and kainate receptors. When a fast application sys-
tem is used it is possible to distinguish the activation of each receptor type based on the kinetics of
the response (Patneau et al., 1994); kainate receptors desensitize quickly to kainate while AMPARs
desensitize slowly or not at all. With the slow application method that we employed, most of the kai-
nate-evoked current should therefore be AMPAR-mediated. To confirm this, we examined the
responses to kainate in the presence of 50 mM GYKI-52466 (GYKI), a selective AMPAR antagonist. In
both Gria3null2–/– and Gria3null2+/+ OPs, kainate-evoked currents were blocked by ~80% in the pres-
ence of GYKI (Figure 5A,C), confirming that most of the kainate-evoked current is AMPAR-mediated
under our experimental conditions. Thus, in Gria3null2–/– mice, activation of AMPARs in OPs gener-
ates less membrane current (and hence less depolarization) than in Gria3null2+/+ controls.
The fact that a significant fraction (~53%) of the normal kainate current is still observed in the
Gria3null2–/– OPs (Figure 5B) indicates that AMPARs are still formed and trafficked to the surface
membrane. It is possible either that the remaining GluA4 subunits form functional homo-tetrameric
receptors, as they can do when expressed on their own in cultured mammalian cells
(Keina¨nen et al., 1990), or that GluA1 is up-regulated in response to loss of GluA2 and GluA3 and
forms GluA1/GluA4 heteromeric or GluA1 homomeric channels. However, by ISH we found no evi-
dence for up-regulation of Gria1 mRNA in Gria3null2–/– SCWM relative to Gria3null2+/+ (Figure 5—
figure supplement 2). Thus, the majority of AMPAR formed in Gria3null2–/– OPs are probably homo-
tetramers of GluA4.
Figure 4 continued
littermate controls. With 100 mM spermine included in the patch pipette, inward rectification of the current was observed in Gria2–/– but not in Gria2 +/–
or Gria2+/+. (D) Rectification index (RI; current at +17 mV/ current at –63 mV) of cells from (C). RI is greatly reduced in Gria2–/– mice (p<10–4, one-way
ANOVA with Bonferroni post-hoc test). (E) Mean kainate-evoked current density (current/capacitance, pA/pF) is the same in P14 Gria2–/–, Gria2+/– and
Gria2+/+ OPs (p=0.73, Kruskal-Wallis with Dunn’s post-hoc test). (F) Immunolabelling for Pdgfra+ OPs (top) and CC1+ OLs (bottom) in P14 Gria2–/– and
Gria2+/+ corpus callosum. (G) EdU incorporation by proliferating OPs (Pdgfra+) in the P14 corpus callosum of Gria2–/– and Gria2+/– mice. The bottom
panels show higher-magnification images of the cells indicated on the top; all Pdgfra+ OPs co-expressed YFP confirming that Sox10-Cre is expressed in
all these cells. (H) There were no significant changes in the densities of either Pdgfra+ OPs (p=0.34, Mann-Whitney test; >600 cells counted per mouse)
or CC1+oligodendrocytes (p=0.40, Mann-Whitney test; >900 cells counted per mouse) at P14. (I) There were no significant differences in the fractions
(%) of EdU+ Pdgfra+ OPs in Gria2–/– versus Gria2+/– (p=0.89, Mann-Whitney test). Numbers of cells and mice analyzed are indicated in (D, E) and (H, I),
respectively. Scale bars: 50 mm.
DOI: 10.7554/eLife.28080.005
The following figure supplements are available for figure 4:
Figure supplement 1. Breeding strategies.
DOI: 10.7554/eLife.28080.006
Figure supplement 2. Sox10-Cre drives recombination in OL lineage cells in the sub-cortical white matter and cerebral cortex.
DOI: 10.7554/eLife.28080.007
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Figure 5. The kainate- evoked current in OPs is reduced in Gria3null2–/– mice. (A) The kainate-evoked current is
blocked reversibly by the AMPAR antagonist GYKI-52466 (GYKI, 50 mM). (B) Mean kainate-evoked current density is
~47% less in Gria3null2–/– OPs compared to Gria3null2+/+ (p<10 4, Student’s t-test). (C) GYKI blocks the kainate-
evoked current in both Gria3null2–/– and Gria3null2+/+ mice (normalized to 100% before GYKI application). (D, E) No
Figure 5 continued on next page
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To determine whether deletion of GluA2/3 from OL lineage cells altered their general
membrane properties, the electrophysiological properties of YFP+ OPs from SCWM of P14
Gria3null2–/– and Gria3null2+/+ mice were compared (Figure 5D–G). Neither the membrane resis-
tance (Rm) nor the capacitance (Cm) of Gria3
null2–/– OPs at –63 mV were different from
Gria3null2+/+ controls (for Rm, p=0.16, Mann-Whitney test and for Cm, p=0.13, Student’s t-test;
Figure 5D,E). In addition, when 20 mV voltage steps were applied from a holding potential of
–63 mV, membrane depolarization evoked a transient inward Na+ current (INa; Figure 5F). Sub-
traction of the linearly scaled capacitive transient and ohmic leak current evoked by a 20 mV
hyperpolarizing step allowed us to estimate the amplitude of INa (Figure 5F). There was no sig-
nificant difference in the INa density between Gria3
null2–/– and Gria3null2+/+ controls (p=0.72,
Mann-Whitney test; Figure 5G), suggesting that altering AMPAR signalling does not regulate
the expression of voltage-gated sodium channels. We conclude that AMPAR signalling does not
much affect the membrane properties of OPs.
Fewer functional axon-OP synapses in Gria3null2–/– white matter
The reduced kainate-evoked current in Gria3null2–/– OPs should be mirrored by a diminished post-
synaptic response at individual axon-OP synapses. To test this, we recorded evoked excitatory post-
synaptic currents (EPSCs) from OPs by applying ‘minimal stimulation’, designed to stimulate a single
axon (see Methods), to the corpus callosum. Surprisingly, the amplitude of the evoked EPSCs
appeared the same in Gria3null2–/– and their Gria3null2+/– controls (p=0.37, Mann-Whitney test;
Figure 6A,B). The evoked responses were blocked by GYKI (50 mM), confirming that they were
AMPAR-mediated (90.3 ± 4.0% inhibition, n = 3 for Gria3null2+/– and 89.5 ± 2.1% inhibition, n = 5 for
Gria3null2–/–).
Spontaneous synaptic currents occur at very low frequency at neuron-OP synapses but their fre-
quency can be increased by application of the secretagogue Ruthenium Red (RR) (Lin and Bergles,
2004; Kukley et al., 2007). RR induces vesicular release at the synapse, increasing the frequency of
miniature EPSCs without affecting their amplitude (Sciancalepore et al., 1998). Bath application of
100 mM RR caused a marked increase in the frequencies of spontaneous EPSCs recorded from OPs of
Gria3null2+/+, Gria3null2+/– and Gria3null2–/– mice. Consistent with the minimal stimulation-evoked
EPSC data, the mean amplitude of individual RR-evoked EPSCs was not reduced in Gria3null2–/– com-
pared to Gria3null2+/– controls or Gria3null2+/+ controls (p=0.32, one-way ANOVA; Figure 6C,D) – sug-
gesting that, at a given synapse, post-synaptic AMPARs generate a similar current in Gria3null2–/– as in
controls. However, the frequency of RR-evoked EPSCs was ~70% less in Gria3null2–/– than in
Gria3null2+/+ controls, and was reduced to an intermediate frequency in Gria3null2+/– controls
(p=210–4, Kruskal-Wallis with Dunn’s post-hoc test; Figure 6E). Consistent with previous reports
(Ziskin et al., 2007), EPSCs were strongly inhibited by the application of 50 mM GYKI (by 88.8 ± 6.5%,
n = 3 for Gria3null2–/–, 83.3 ± 3.8%, n = 2 for Gria3null2+/– and 93.8 ± 2.4%, n = 2 for Gria3null2+/+), prov-
ving that they are AMPAR-mediated. The reduction in frequency of EPSCs suggests either that the
probability of RR-evoked presynaptic vesicle release is decreased in Gria3null2–/– or, more likely, that
fewer synapses are made between neurons and OPs inGria3null2–/– mice.
Figure 5 continued
significant changes in membrane resistance Rm (D), p=0.16, Mann-Whitney test) or capacitance Cm (E), p=0.13,
Student’s t-test) of OPs from Gria3null2–/– compared to Gria3null2+/+. (F) INa recorded from P14 Gria3
null2+/+ OPs.
Top current traces are responses to voltage steps in 20 mV increments from  63 mV, showing the capacity current
and the subsequent (much smaller) ionic current changes evoked by the voltage steps. Bottom trace is after
subtraction of the linearly scaled response to a 20 mV hyperpolarizing step. (G) There was no significant change in
INa density in Gria3
null2–/– compared to Gria3null2+/+ controls (p=0.72, Mann-Whitney test). Numbers of cells
analyzed are indicated in (B–E, G).
DOI: 10.7554/eLife.28080.008
The following figure supplements are available for figure 5:
Figure supplement 1. Gria2 is successfully knocked out in Gria3null2–/– mice.
DOI: 10.7554/eLife.28080.009
Figure supplement 2. Gria1 is not up-regulated in cells in the corpus callosum of Gria3null2–/– mice.
DOI: 10.7554/eLife.28080.010
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Figure 6. AMPAR-mediated synaptic input is reduced in Gria3null2–/– mice. (A) EPSCs evoked by minimal stimulation in OPs in the SCWM of P14
Gria3null2+/– and Gria3null2–/– mice. Black triangle marks the time point of stimulation. (B) The amplitude of minimal stimulation-evoked EPSCs is not
affected in Gria3null2–/– compared to Gria3null2+/– (p=0.37, Mann-Whitney test). (C) EPSCs evoked in OPs by Ruthenium Red (RR, 100 mM) in the corpus
callosum of P14 Gria3null2+/+ and Gria3null2–/– mice. Single events marked by asterisks (red) are enlarged on the right. (D) The amplitude of RR-evoked
Figure 6 continued on next page
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To distinguish between these possibilities we estimated the paired pulse ratio (PPR) at neuronal-
OP synapses in SCWM. The PPR was calculated from two consecutive evoked EPSCs 25 ms apart,
recorded from patch-clamped OPs. There was no difference in PPR of Gria3null2–/– OPs versus
Gria3null2+/+ OPs (p=0.95, Student’s t-test; Figure 6F). This suggests that the reduction in EPSC fre-
quency is not due to a change in presynaptic glutamate release but rather because fewer active syn-
apses are formed or maintained in Gria3null2–/– mice.
OL survival is reduced, and OL accumulation delayed, in Gria3null2–/–
white matter
Having established that OPs in Gria3null2–/– mice receive reduced synaptic input, we asked whether
the development of OL lineage cells was affected. We counted CC1+ differentiated OLs in the
SCWM of early postnatal (P7, P14, P21) and adult (P70) Gria3null2–/– and Gria3null2+/+ mice. There
was a ~22% reduction in the density of OLs at P7 and a ~27% reduction at P14 in Gria3null2–/– com-
pared to Gria3null2+/+ controls (p=0.018 at P7; p=0.001 at P14, t–tests with Holm-Bonferroni correc-
tion; Figure 7A,B). By P21 (p=0.14) and P70 (p=0.48, Mann-Whitney test with Holm-Bonferroni
correction) this difference was no longer significant. These data suggest that production or survival
of OLs is impaired in Gria3null2–/– mice in the early postnatal period.
Enpp6 (ectonucleotide pyrophosphatase/phosphodiesterase family member 6; an ecto-enzyme
with choline-specific glycerophosphodiester phosphodiesterase activity: Morita et al., 2016) is a
recently-identified marker of newly-differentiating OLs that is strongly down-regulated in mature
OLs (Zhang et al., 2014; Xiao et al., 2016). The number of Enpp6+ cells present at any given time
therefore provides a measure of the rate of formation of OLs from their precursors (OPs). We visual-
ized Enpp6+ cells in the SCWM of P14 Gria3null2–/–and Gria3null2+/+ mice by ISH. This revealed
a ~26% reduction of Enpp6+ newly-differentiated OLs in Gria3null2–/– mice compared to their
Gria3null2+/+ littermates (p=0.004, Mann-Whitney test; Figure 7C,D), reinforcing our conclusion that
the rate of generation or survival of newly-forming OLs is reduced by loss of GluA2/GluA3. That is,
glutamate signalling through AMPARs in OPs normally stimulates OPs to exit the cell cycle and dif-
ferentiate into OLs, or else enhances the survival of immature OLs once they have formed.
We attempted to distinguish between these two scenarios by comparing the density of Pdgfra+
OPs in Gria3null2–/– and control mice. If OPs continue to divide but are unable to differentiate into
OLs in the Gria3null2–/– mice we might expect the density of OPs to increase. We found no significant
differences in the density of OPs in Gria3null2–/– SCWM compared to Gria3null2+/+ controls (p=0.6 at
P3; p=0.85 at P7; p=0.07 at P14; p>0.99 at P21 and p=0.76 at P70, t–test or Mann-Whitney test
with Holm-Bonferroni correction; Figure 7E,F). This suggests that reduced accumulation of OLs in
the SCWM of Gria3null2–/– mice is not caused by a reduction in the rate of differentiation of OPs.
However, the reduction in OL density might have resulted from a reduced proliferation rate of OPs –
that is, more slowly dividing OPs produce fewer OLs. To assess OP division rates we administered
EdU to mice at P3, P7, P14 and P70 (see Materials and methods). The fraction of Pdgfra+ OPs that
incorporated EdU (‘labelling index’) was not detectably different in Gria3null2–/– versus Gria3null2+/+
SCWM at any age examined (p=0.69 at P3; p=0.69 at P7; p=0.7 at P14; p=0.34 at P70, Mann-Whit-
ney tests; Figure 7—figure supplement 1A,B), nor was there any difference in the fraction of
Pdgfra+ OPs in the P14 SCWM that immunolabelled for Ki67, a marker of actively dividing cells
(p=0.78, Student’s t-test; Figure 7—figure supplement 1C,D). These data indicate that the OP divi-
sion rate is not affected by loss of GluA2 and GluA3.
We performed anti-cleaved Caspase-3 and anti-Olig2 immunolabelling to test directly whether
apoptotic death of OL lineage cells was increased by loss of GluA2/GluA3. The proportion of Olig2+
cells that labelled for cleaved Caspase-3 in Gria3null2+/+ controls at P14 was 22.7 ± 1.2% (n = 8
mice). In Gria3null2–/– mice the cleaved Caspase-3-positive fraction was increased by a factor ~1.19
Figure 6 continued
EPSCs is not affected in Gria3null2–/– compared to Gria3null2+/+ or Gria3null2+/– (p=0.73, one-way ANOVA with Bonferroni post-hoc test). (E) The
frequency of RR-evoked EPSCs is ~70% less in Gria3null2–/– compared to Gria3null2+/+ (p=210–4, Kruskal-Wallis with Dunn’s post-hoc test). (F) There was
no change in the paired-pulse ratio in Gria3null2–/– compared to Gria3null2+/+ (p=0.95, Student’s t-test). Numbers of cells analyzed are indicated in (B,
D–F).
DOI: 10.7554/eLife.28080.011
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Figure 7. Gria3null2–/– mice generate fewer OLs in the corpus callosum. All data at P14 unless otherwise stated. (A) Immunolabelling for Olig2 and CC1
antigen visualizes differentiated OLs in Gria3null2+/+ and Gria3null2–/– mice. (B) The density of CC1+ OLs is significantly less (by ~27%) in Gria3null2–/–
mice relative to Gria3null2+/+ controls at both P7 and P14 (t- or Mann-Whitney tests with Holm-Bonferroni correction; n = 7, 14, 7 and 6 mice at P7, P14,
P21 and P70, respectively, for Gria3null2–/–; n = 5, 14, 9 and 6 mice at P7, P14 and P21 for Gria3null2+/+. >800 cells were counted per mouse at all ages).
Figure 7 continued on next page
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(increased by 19.4 ± 4.2%, p=0.002, Student’s t-test with Welch’s correction; Figure 7G,H.). Pub-
lished expression databases suggest that AMPAR subunits are expressed in pre-myelinating OLs as
well as in OPs, though at a lower level in the former (Cahoy et al., 2008; Zhang et al., 2014). We
confirmed by double ISH for Enpp6 and Gria2, Gria3 or Gria4 that some newly-forming Enpp6+ OLs
express one or more GluA subunits (Figure 7—figure supplement 2). Together, these data indicate
that signalling through AMPAR in OL lineage cells promotes survival of newly-differentiating OLs.
Reduced total myelin in Gria3null2–/– white matter
A reduction in the number of OLs would be expected to lead to a reduction in myelination. To test
this, we examined P14 Gria3null2–/– and Gria3null2+/+ brains by electron microscopy (EM) and
counted the number of transverse myelin figures viewed in parasagittal sections of SCWM
(Figure 8A,B). This revealed a ~20% reduction in the number of myelin cross-sections in Gria3null2–/–
normalized to littermate controls at P14 (p=0.02, Mann-Whitney test), consistent with the ~27%
reduction in the number of OLs in Gria3null2–/– mice at the same age (see previous section; Figure 7).
Therefore, the most parsimonious explanation for the myelin deficit is that the number of OLs is
decreased without a compensatory change in the number or length of myelin internodes made by
individual OLs. To test this, we dye-filled OLs from P14 Gria3null2–/– and Gria3null2+/+ brain slices and
measured the lengths and numbers of internodes associated with individual OLs. There was no
change in the average length of internodes (p=0.47, Student’s t-test) or the average number of
internodes per OL (p=0.26, Mann-Whitney test; Figure 8C,D). In addition, by EM we found no
change in the range or frequency distributions of myelinated (Figure 8E) or unmyelinated
(Figure 8F) axon diameters at P14, arguing against an indirect effect of the Gria3null and/or Gria2–/–
mutations on OLs and myelin via axons – for example, because the fraction of axons that exceeded
the size threshold for myelination might have been reduced in the Gria mutants. We also measured
myelin thickness, expressed as g-ratio, and found no significant change (p=0.29, Mann-Whitney test;
Figure 8G).
At P70 there was no longer any significant difference in the number of myelin cross-sections
per unit area observed by EM (p=0.57, Mann-Whitney test; Figure 8B), consistent with the
fact that the numbers of OLs identified by CC1 immunolabelling were similar in Gria3null and
Gria3null2–/– at this age (Figure 7B). At P70, as at P14, there was no change in the g-ratios of
myelinated axons in Gria3null versus Gria3null2–/– corpus callosum (p=0.29, Mann-Whitney test;
Figure 8H). Our data are consistent with a model in which each OL synthesizes a similar total
length of myelin sheath in Gria3null2–/– mice as in controls and the overall synthesis of myelin is
reduced in proportion to the reduced number of OLs.
Triple knockout of GluA2/ GluA3/ GluA4 in the OL lineage
Since ~50% of the kainate-evoked current persisted in Gria3null2–/– mice, we questioned whether
deletion of all three AMPAR subunits expressed in the OL lineage (GluA2, GluA3 and GluA4) might
Figure 7 continued
Right hand side of the graph visualizes the spread of data at P14. (C) ISH for Enpp6 in Gria3null2+/+ and Gria3null2–/– mice. (D) There is a ~26% reduction
in the density of Enpp6 cells in Gria3null2–/–compared to Gria3null2+/+ (p=0.004, Mann-Whitney test). (E) Pdgfra+ OPs in Gria3null2+/+ and Gria3null2–/–
mice. (F) There were no significant differences in the density of Pdgfra+ OPs in Gria3null2–/– versus Gria3null2+/+ mice between P3-P70, although there
was a trend towards transient reduction in cell density at P14 in Gria3null2–/– (t- or Mann-Whitney tests with Holm-Bonferroni correction; n = 4, 8, 14, 7
and 8 mice at P3, P7, P14, P21 and P70, respectively, for Gria3null2–/–, n = 4, 6, 14, 9 and 7 mice at P3, P7, P14, P21 and P70 for Gria3null2+/+. >800 cells
were counted per mouse at all ages). (G) Cleaved Caspase-3+, Olig2+ OL lineage cells in SCWM of P14 Gria3null2–/– mice. Cells in the rectangle (dotted
line) are shown on the right at higher magnification. (H) There was a ~19% increase in the fraction of Olig2+ cells that expressed cleaved Caspase-3 in
Gria3null2–/– compared to Gria3null2+/+ littermate controls (p=0.002, Student’s t-test with Welch’s correction; >800 Olig2+ cells were counted in each
mouse). Numbers of mice analyzed are indicated in (D) and (H). Scale bars: 50 mm.
DOI: 10.7554/eLife.28080.012
The following figure supplements are available for figure 7:
Figure supplement 1. The division rate of OPs in the corpus callosum is not affected in Gria3null2–/– mice.
DOI: 10.7554/eLife.28080.013
Figure supplement 2. mRNA encoding GluA2-4 continue to be expressed in Enpp6+ early-differentiating OLs.
DOI: 10.7554/eLife.28080.014
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Figure 8. Less myelin in Gria3null2–/– corpus callosum. (A) Transmission electron micrograph of P14 corpus callosum from Gria3null2+/+ and Gria3null2–/–
mice. Scale bar: 5 mm. (B) There was a ~20% reduction in the number of cross-sectional myelin figures per unit area in Gria3null2–/– compared to
Gria3null2+/+ mice at P14, but not at P70 (p=0.02 at P14, p=0.57 at P70, Mann-Whitney tests). (C) Dye-filled OLs in P14 corpus callosum of Gria3null2+/+
and Gria3null2–/– mice. (D) There was no difference in the length of the internodes (p=0.47, Student’s t-test) or the number of internodes per OL
Figure 8 continued on next page
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result in a more severe phenotype. We therefore generated triple-KO mice with the genotype
Sox10-Cre: Gria3null: Gria2flox/flox: Gria4flox/flox: Rosa-YFP (referred to as Gria3null2–/–4–/–) (Figure 4—
figure supplement 1C). Littermate controls for assessment of cell densities and myelination were
Gria3null with two functional copies of Gria2 and Gria4 because they did not carry the Sox10-Cre
transgene. For electrophysiological experiments that used YFP fluorescence for OP identification
(requiring both Sox10-Cre and Rosa-YFP transgenes), Gria3null2–/– littermates carrying wild type
alleles of Gria4 were used for comparison (Figure 4—figure supplement 1C).
Whole-cell patch-clamp recordings of YFP+ OPs in the P14 SCWM revealed that the current den-
sity of kainate-evoked current elicited by application of 100 mM kainate at –63 mV was dramatically
reduced in Gria3null2–/–4–/– to ~23% of that observed in Gria3null2–/– littermates (p<10–4, Student’s
t-test with Welch correction; Figure 9A,B), suggesting that very few, if any, AMPARs are present in
Gria3null2–/–4–/– OPs (the kainate-evoked current in Gria3null2–/–4–/– OPs is ~13% of that in Gria3null
OPs; compare Figures 5B and 9B). In support of this, application of 50 mM GYKI blocked the kai-
nate-evoked current in Gria3null2–/–4–/– only by ~39% as opposed to ~80% in Gria3null2–/– (p=0.005,
Mann-Whitney test; Figure 9C). Moreover, the I-V relationship of the kainate-evoked current was
nearly linear in Gria3null2–/–4–/– OPs, not inwardly-rectifying as in Gria3null2–/– (different rectification
indices, p=0.005, Mann-Whitney test; Figure 9D,E). This suggests that receptors other than AMPAR
– most likely kainate receptors (KAR) – mediate the majority of the (much reduced) kainate-evoked
response in Gria3null2–/–4–/– OPs. Consistent with the apparent lack of AMPAR in Gria3null2–/–4–/–
OPs, and with AMPARs rather than KARs being the main receptor type activated at axon-OP synap-
ses, almost no EPSCs were detected following application of 100 mM RR to brain slices (significantly
less than in Gria3null2–/–; p=0.03, Mann-Whitney test) (Figure 9F,G). These data show that AMPAR
signalling is essentially abolished in Gria3null2–/–4–/– OPs.
We counted CC1+ OLs and Pdgfra+ OPs in the SCWM of Gria3null2–/–4–/– mice at P14 and P53. At
P14 there was a ~22% reduction in the density of OLs relative to Gria3null controls and at p53
a ~26% reduction (p=0.026 at P14; p=0.029 at P53, Mann-Whitney test, Figure 10A,B) without a
concomitant change in the density of OPs (p=0.11 at P14; p=0.7 at P53, Mann-Whitney test)
(Figure 10C,D). The fraction of Olig2+ cells that expressed cleaved Caspase-3 in SCWM of P14
Gria3null controls was 24.8 ± 0.8% (n = 5 mice) and this increased in Gria3null2–/–4–/– mice by a factor
of ~1.24 (increased by 24.2 ± 4.8%, p=0.004, Mann-Whitney test; Figure 10E,F). As observed for
Gria3null2–/– mice, there was no significant change in the average length (p=0.93, Student’s t-test) or
number (p=0.41, Student’s t-test) of internodes per individual Gria3null2–/–4–/– OL, analyzed by dye-
filling OLs in brain slices (Figure 10G,H). Taken together, our data demonstrate that signalling
through AMPAR stimulates OL production and myelination in the white matter by enhancing survival
of newly-formed OLs, without a detectable effect on OL morphology.
Discussion
Previous studies have shown that signalling between electrically active axons and OL lineage cells
can influence several aspects of OL development, including proliferation and differentiation of OPs
and the initiation and stabilization of myelin internodes. We have now provided the first direct evi-
dence that synaptic signalling through AMPARs in OPs and/or early OLs modulates OL development
in vivo. Knock-out of Gria2 or Gria3 alone had no discernible effect on OL development but double-
KO of Gria2/3 in the OL lineage reduced, and triple-KO of Gria2/3/4 abolished, AMPAR-mediated
signalling in OPs and led to reduced accumulation of mature OLs and myelin without affecting the
proliferation or number of OPs. The presence of GluA2 subunits (encoded by Gria2) is known to
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(p=0.26, Mann-Whitney test) in Gria3null2–/– compared to Gria3null2+/+ mice. (E) Frequency distribution of myelinated axon diameters from P14
Gria3null2+/+ and Gria3null2–/– mice (100–350 axons measured in each of three mice per group). (F) Frequency distribution of unmyelinated axon
diameters from P14 Gria3null2+/+ and Gria3null2–/– mice (>300 axons measured in each of three mice per group). (G) Scatter plots of g-ratios as a
function of axon diameter in P14 Gria3null2+/+ and Gria3null2–/– mice (>260 axons measured from four mice per group). (H) Scatter plots of g-ratios as a
function of axon diameter in P70 Gria3null2+/+ and Gria3null2–/– mice (>150 axons measured from each of three mice per group). Number of mice
analyzed is indicated in (B) and number of cells analyzed in (D).
DOI: 10.7554/eLife.28080.015
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Figure 9. Gria3null2–/–4–/– mice lack AMPAR-mediated inputs. (A) The kainate-evoked current is greatly reduced in OPs of P14 Gria3null2–/–4–/– mice
compared to Gria3null2–/– littermates and is less effectively blocked by the AMPAR antagonist GYKI-52466 (GYKI, 50 mM). (B) Mean kainate-evoked
current density in P14 Gria3null2–/–4–/– OPs is ~24% that of Gria3null2–/– littermates (p<10–4, Student’s t-test with Welch correction), corresponding to
~13% that of Gria3null OPs (Figure 5B). (C) GYKI blocks the kainate-evoked current by ~80% in Gria3null2–/–, but only by ~39% in. Gria3null2–/–4–/– mice
Figure 9 continued on next page
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suppress the Ca2+ permeability of AMPARs (provided GluA2 is the Q –> R edited isoform). The fact
that knockout of Gria2 alone did not affect OL development implies that the reduction in OL number
observed in the Gria2/3 and Gria2/3/4 mutants results from an aspect of AMPAR signalling other
than Ca2+ permeability, for example the induced depolarization or the Na+ influx that it produces.
Thus, AMPAR signalling in OPs and/or early-differentiating OLs is a positive regulator of OL devel-
opment; we speculate that this favours myelination of active axons that are releasing glutamate, thus
accelerating development of a functioning CNS.
Effect of AMPAR subunit knockouts on synaptic input to OPs
OPs in developing white matter receive glutamatergic synaptic input from unmyelinated axons in
white matter. Most glutamatergic synaptic current in OPs is via AMPAR (Lin and Bergles, 2004;
reviewed by Bergles and Richardson, 2015). We have shown that OL lineage cells in the SCWM
express mRNA encoding AMPAR subunits GluA2, GluA3 and GluA4 but not GluA1 - the same spec-
trum of AMPAR subunits reported for rat and mouse OPs in culture (Patneau et al., 1994;
Zhang et al., 2014). Knocking out GluA2 and GluA3 in OPs reduced the AMPAR-mediated current
to ~53% of normal, while knocking out all three subunits GluA2/3/4 reduced it to ~13% of normal.
Surprisingly, we found that in OPs lacking GluA2 and GluA3 the amplitude of RR-induced synaptic
events was unchanged while their frequency was reduced to <30% of normal, while in OPs lacking
all AMPAR subunits their frequency was reduced to only ~1% of control. The simplest interpretation
is that there are fewer AMPAR-containing synapses in double-KO OPs (and almost none in triple-
KOs), but that those synapses that survive contain a normal number of AMPARs. In support of this it
has been shown in neurons that, when the number of post-synaptic AMPARs is increased experimen-
tally, an increase in frequency of EPSPs with no change in their amplitude is observed (Sinnen et al.,
2017), suggesting that the number of functioning synaptic connections is determined, at least in
part, by the number of postsynaptic AMPARs available, and that quantal amplitude is regulated
independently of the number of synaptic connections. In the GluA2/3 double-KO the surviving syn-
apses must contain exclusively or predominantly GluA4 subunits, which are known to form functional
homo-tetramers (Keina¨nen et al., 1990). We cannot tell whether separate ‘GluA4-only’ and ‘GluA4-
lacking’ synapses are normally present on OPs, although distinct sets of GluA2/GluA3-containing
and GluA2/GluA3-lacking synapses have been described for neurons in the carp retina
(Schultz et al., 2001). In any case our data provide striking genetic confirmation that almost all glu-
tamatergic synaptic input to OPs is via AMPARs composed of GluA2, GluA3 and GluA4 subunits.
AMPAR signalling does not affect OP proliferation
We found that OP proliferation and OP number were normal in Gria3null2–/– and Gria3null2–/–4–/–
mice. Previous studies disagree over whether activity-driven glutamate release stimulates, inhibits or
has no effect on proliferation of OPs. Experiments with organotypic rat or mouse cerebellar slice cul-
tures found that adding AMPA/ kainate receptor agonists inhibited proliferation of OPs (Yuan et al.,
1998; Fannon et al., 2015). However, direct electrical stimulation of glutamatergic pyramidal neu-
rons in the rat motor cortex was found to stimulate OP proliferation in the cerebro-spinal tract
(Li et al., 2010), and optogenetic stimulation of projection neurons in mouse premotor cortex stimu-
lated OP proliferation in the premotor pathway, including the SCWM (Gibson et al., 2014). More-
over, blocking the activity of retinal ganglion cells (RGCs) and their axons in the mouse optic nerve
by intra-ocular injection of tetrodotoxin inhibited OP proliferation (Barres and Raff, 1993). On the
other hand, sensory deprivation of mouse barrel cortex by whisker removal (Mangin et al., 2012;
Hill et al., 2014), which presumably restricts glutamate release in the cortex, increased OP prolifera-
tion in the barrels, in keeping with the data from brain slice cultures (Yuan et al., 1998;
Figure 9 continued
(p=0.005, Mann-Whitney test). (D) Current-voltage plot showing inward rectification in OPs of P14 Gria3null2–/– mice but not Gria3null2–/–4–/–, when 100
mM spermine is included in the patch pipette. (E) Rectification indices of cells recorded in (D) are significantly increased in Gria3null2–/–4–/– compared to
Gria3null2–/– littermates (p=0.005, Mann-Whitney test). (F) EPSCs evoked in OPs by Ruthenium Red (RR, 100 mM) in the corpus callosum of P14
Gria3null2–/– and Gria3null2–/–4–/– mice. (G) The frequency of RR-evoked EPSCs is dramatically reduced in Gria3null2–/–4–/– compared to Gria3null2–/–
littermates (p=0.03, Mann-Whitney test). Numbers of cells analyzed are indicated in (B), (C), (E) and (G).
DOI: 10.7554/eLife.28080.016
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Figure 10. Gria3null2–/–4–/– mice generate fewer OLs in the corpus callosum. (A) CC1 immunolabelling marks differentiated OLs in Gria3null and
Gria3null2–/–4–/– mice. (B) The density of CC1+ OLs is significantly less (by ~22% at P14 and ~26% at P53) in Gria3null2–/–4–/– mice relative to Gria3null
controls (p=0.026 at P14, p=0.029 at P53, Mann-Whitney test; >900 cells were counted per mouse at all ages). (C) Pdgfra+ OPs in Gria3null and
Gria3null2–/–4–/– mice. (D) There were no significant differences in the density of Pdgfra+ OPs at P14 or P53 in Gria3null2–/–4–/– versus Gria3null mice
Figure 10 continued on next page
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Fannon et al., 2015). Against all of the above, a recent in vivo study, in which glutamate release
from the axons of mouse RGCs was genetically attenuated, found no effect on OP proliferation in
the optic tract (Etxeberria et al., 2016). Genetic block of vesicular release from longitudinally-pro-
jecting axons in the zebrafish spinal cord also had no effect on OP proliferation (Hines el al., 2015;
Mensch et al., 2015), although numbers of OL lineage cells were reduced by ~10%, apparently
because of reduced specification of OPs from their stem cell precursors in the embryonic ventricular
zone (Mensch et al., 2015). It is unlikely that we would have detected an effect of this size, even
assuming it would not have been overridden by homeostatic controls on cell number in the perinatal
mouse brain.
The data cited above are contradictory and confusing. However, the experiments are not directly
comparable to each other. For example, pharmacological manipulation of slice cultures is not tar-
geted to specific cells and opens the possibility that there might be indirect effects mediated via
neurons, some of which also express AMPA/ kainate receptors. The same reservation might apply to
some of the in vivo experiments cited above – on top of which, stimulating or inhibiting electrical
activity or vesicular release in vivo is likely to affect more than just AMPAR-mediated signalling. For
example, electrically active neurons release Neuroligin-3 (NLGN3), a mitogen for malignant glioma
cells, which are believed to be derived from and closely related to OPs (Venkatesh et al., 2015).
Our conditional knockout approach is tightly focused on AMPAR-mediated effects in OL lineage
cells and avoids confounding influences by other signalling pathways, direct or indirect. We con-
clude, as discussed below, that signalling through AMPAR in OL lineage cells promotes survival of
newly-differentiating OLs.
AMPAR signalling promotes the survival of differentiating OLs
Reduced AMPAR signalling in the SCWM of our Gria3null2–/– mice resulted in a modest (~27%)
reduction in OL accumulation in the early postnatal period (around P14), but OL numbers recovered
to normal levels in adult mice. Additional deletion of Gria4 did not reduce the number of OLs fur-
ther, but the reduction now persisted into adulthood. We assume that these changes reflect the loss
of synaptic currents that we have documented above. The relatively modest effect on OL dynamics
of ablating AMPAR might reflect the fact that glutamate can signal to OPs through receptors other
than AMPAR (including NMDAR, KAR or mGluR), and that glutamate is only one of a number of sig-
nalling molecules that communicate axonal activity to OPs.
Previous studies into the effects of glutamatergic signalling on OL differentiation have been con-
flicting. Experiments in dissociated cell cultures and slice cultures from rat or mouse indicated that
blocking AMPA/ kainate receptors promoted OL differentiation (Gallo et al., 1996; Yuan et al.,
1998; Fannon et al., 2015) while preventing their further maturation and expression of myelin pro-
teins (Fannon et al., 2015). In vivo, manipulating electrical activity pharmacologically
(Demerens et al., 1996), electrically (Li et al., 2010), optogenetically (Gibson et al., 2014) or physi-
ologically (Simon et al., 2011; McKenzie et al., 2014; Xiao et al., 2016) have suggested that axonal
activity promotes OL generation and myelin formation in rats and mice. However, inhibiting vesicular
release from axons in the developing zebrafish spinal cord by pan-neuronal expression of tetanus
toxin had no effect on OL differentiation, but reduced the number and length of myelin sheaths syn-
thesized by individual OLs (Hines et al., 2015; Mensch et al., 2015). This effect was observed for
OLs that myelinated some but not all classes of axon (Koudelka et al., 2016) – consistent with the
idea that there are both activity-dependent and –independent mechanisms of myelination
(Lundgaard et al., 2013). However, tetanus toxin inhibits all SNARE-dependent vesicular release,
including release of neurotransmitters other than glutamate (e.g. ATP and GABA) that have also
Figure 10 continued
(p=0.11 at P14; p=0.7 at P53, Mann-Whitney test; >400 cells were counted per mouse at all ages). (E) Cleaved Caspase-3+, Olig2+ OL lineage cells in
Gria3null2–/–4–/– mice. Cells in the rectangle (dotted line) are shown on the right at higher magnification. (F) There was a ~24% increase in the fraction of
Olig2+ cells that expressed cleaved Caspase-3 in Gria3null2–/–4–/– compared to Gria3null mice (p=0.004, Mann-Whitney test; >1500 Olig2+ cells were
counted in each mouse). (G) Dye-filled OLs in P14 corpus callosum of Gria3null and Gria3null2–/–4–/– mice. (H) There was no change in the length of the
internodes (p=0.93, Student’s t-test) or the number of internodes per OL (p=0.41, Student’s t-test) in Gria3null2–/–4–/– compared to Gria3null mice.
Numbers of mice analyzed are indicated in (B), (D) and (F) and numbers of cells in (H). Scale bars: 50 mm.
DOI: 10.7554/eLife.28080.017
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been implicated in the control of myelination (Stevens et al., 2002; Ishibashi et al., 2006;
Zonouzi et al., 2015; Hamilton et al., 2017). Further complicating the picture, inhibition of gluta-
mate release from the axons of RGCs increased OL number in the mouse optic tract
(Etxeberria et al., 2016). Although the latter study preferentially affected glutamate signalling it did
not separate AMPAR-mediated effects from those mediated by e.g. NMDAR or mGluR.
We found that the reduced number of differentiated OLs in the double- and triple-KOs was a
result of increased death of OL lineage cells – most likely newly-formed, pre-myelinating OLs. In
keeping with this, we found that Gria2-4 continue to be expressed in Enpp6+ early-differentiating
OLs, suggesting that some AMPAR-mediated signalling can still occur during the early stages of OL
differentiation, even though AMPAR-mediated EPSCs are down-regulated in maturing OLs
(Kukley et al., 2010; De Biase et al., 2010). Synaptic input – and activation of AMPARs in particular
– has been shown to promote neuronal survival during early postnatal development (Heck et al.,
2008) and a recent study showed that sensory input from the whiskers to somatosensory barrel cor-
tex promotes the survival of newly-differentiating OLs (Hill et al., 2014). Thus, AMPAR signalling in
OL lineage cells could be one of the mechanisms ensuring that only pre-myelinating OLs that make
contact with active axons survive to myelinate in the longer term (Barres et al., 1992,
1993; Trapp et al., 1997).
Electrical activity is also known to affect the terminal stages of OL differentiation, that is, myelin
synthesis (Demerens et al., 1996; Wake et al., 2011; Lundgaard et al., 2013; Gibson et al., 2014;
Wake et al., 2015). Glutamate receptors other than AMPAR, that is, NMDAR and mGluR, have
been suggested to regulate this process (Wake et al., 2011; Lundgaard et al., 2013), possibly by
regulating the energy supply to developing OLs (Saab et al., 2016) – although a major effect of
NMDARs in vivo has been disputed (De Biase et al., 2011; Guo et al., 2012). In our present study
we found that the amount of myelin in the SCWM of Gria3null2–/– mice was reduced in proportion to
the reduced number of OLs. The g-ratio, as well as the internode number and length, were
unchanged, suggesting that once a pre-myelinating OL makes a commitment to myelinate an axon,
the process continues until a normal internode number and length, and a normal number of myelin
wraps are achieved. Therefore, the activity-dependent regulation of internode length that has been
observed in vitro (Wake et al., 2015) and in vivo (Koudelka et al., 2016) is presumably mediated by
glutamate receptors other than AMPAR, or by signals other than glutamate. In short, we have shown
that AMPAR signalling stimulates myelin formation in mice by increasing the number of myelinating
OLs that develop from OPs, not by regulating myelin synthesis per se.
In summary, our study demonstrates that AMPAR signalling in OL lineage cells promotes OL
development and myelination during postnatal development. Elucidating further mechanisms of sig-
nalling from neurons to OL lineage cells will be crucial for understanding developmental myelination
and for devising therapies to promote remyelination in diseases of the white matter.
Materials and methods
Transgenic mice
AMPAR subunits GluA1-4 are encoded by separate genes Gria1-4. In the Gria2flox/flox line, exon 11
of Gria2 is flanked by loxP sites (Shimshek et al., 2006a). Gria4flox/flox mice (Gria4tm1Mony;
MGI:3798453) also have exon 11 flanked by loxP sites (Fuchs et al., 2007). Gria3 null mice (Gria3 –/–
or Gria3 –/Y) have exon 11 deleted in the germ line (Sanchis-Segura et al., 2006). Rosa-YFP reporter
mice (Srinivas et al., 2001) allow Cre-induced expression of the enhanced yellow fluorescent protein
(YFP). Most transgenic lines were maintained as homozygous breeding colonies. Sox10-Cre mice
(line 22–7) (Matsuoka et al., 2005) express Cre recombinase under Sox10 transcriptional control in
a phage artificial chromosome (PAC). They were maintained as a heterozygous breeding colony and
only female carriers were used for experiments, because Sox10-Cre is expressed and causes recom-
bination in the male germ line. Our breeding schemes are shown in Figure 4—figure supplement
1A–C. Mice were maintained on a 12 hr light-dark cycle. The day of birth was designated postnatal
day 0 (P0). For histological experiments the age of the animals is stated; for electrophysiological
experiments a range of ages P13-P16 was used, referred to collectively as P14.
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Electrophysiology
Coronal slices (225 mm thick) including the corpus callosum were prepared from the forebrain of
P13-15 mice. Sections were prepared in ice-cold oxygenated solution containing 124 mM NaCl, 26
mM NaHCO3, 2.5 mM KCl, 1 mM NaH2PO4, 2.5 mM CaCl2, 2 mM MgCl2, 10 mM D-glucose, 1 mM
Na-kynurenate, pH 7.4, bubbled with a 95% O2/5% CO2 mixture. After sectioning, slices were main-
tained in the same solution at 20–25˚C before use. Brain slices were superfused with either HEPES-
buffered solution containing 140 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES,
1 mM NaH2PO4, and 10 mM D-glucose, pH 7.4 (adjusted with NaOH), bubbled with 100% O2, or
with bicarbonate-buffered solution containing 124 mM NaCl, 26 mM NaHCO3, 2.5 mM KCl, 1 mM
NaH2PO4, 2.5 mM CaCl2, 1 mM MgCl2, 10 mM D-glucose, pH 7.4, bubbled with 95% O2/5% CO2.
For Ruthenium Red (RR) –mediated potentiation of the frequency of excitatory postsynaptic current
(EPSCs) we used bicarbonate-buffered solution; for other experiments we used HEPES-buffered
solution.
Patch pipettes were pulled from thick-walled borosilicate glass capillaries (type GC150F-10;
Harvard Apparatus) to a resistance of 3–5 MW. For RR experiments the intracellular solution con-
tained 140 mM CsCl, 10 mM HEPES, 2 mM MgATP, 0.5 mM CaCl2, 4 mM NaCl, 5 mM EGTA,
0.052 mM Alexa Fluor 568, pH 7.3 (adjusted with CsOH). For the rest of the experiments the
intracellular solution contained CsCl 145 mM, 10 mM HEPES, 4 mM MgATP, 2.5 mM NaCl, 1 mM
EGTA, 0.052 mM Alexa Fluor 568, pH 7.2 (adjusted with CsOH). When indicated, spermine
(Sigma) was added to the intracellular solution at a final concentration of 100 mM. For both solu-
tions the junction potential of –3 mV has been corrected for.
YFP-expressing OPs in the corpus callosum were selected for whole-cell patch-clamping based
on their size and shape in the fluorescence microscope, and their membrane properties. Cells with
voltage-gated Na+ currents, 1 GW membrane resistance and 35 pF capacitance were considered
to be OPs. Due to the high membrane resistance of OPs, recordings were made without series resis-
tance compensation. In some experiments the following drugs were applied by adding to the super-
fusing extracellular solution: kainic acid monohydrate (100 mM; Sigma) to activate AMPAR and
kainate receptors, GYKI52466 (GYKI; 50 mM; Sigma) to block AMPARs, or RR (100 mM; Sigma) to
evoke transmitter release. To record the OP’s voltage-gated currents and the I–V relationship of
drug-evoked currents, 20 mV voltage steps of 200 ms duration were applied from a holding poten-
tial of –63 mV (voltage range from –103 mV to +17 mV). For RR-evoked EPSCs the holding potential
was –83 mV to increase the driving force for excitatory synaptic events and thus increase the chance
of detecting the events.
For evoked synaptic responses cells were clamped at –63 mV and the responses were elicited by
stimulation (Digitimer Limited) of callosal axons using a glass micropipette filled with external solu-
tion (resistance 1–2 MW) placed ~150–200 mm away from the recorded cell in the corpus callosum.
For minimal stimulation, activating only one axon with input to the recorded cell, the stimulus
strength was gradually reduced until no post-synaptic current was detected in the patch-clamped
OP. Then the stimulus was gradually increased until a post-synaptic response was detected. In each
cell 50–80 trials under these conditions were recorded and analyzed. The amplitude of the unitary
EPSC was obtained by averaging those events where an EPSC was observed. For estimation of
paired-pulse ratio (PPR), two strong (90 V, 800 ms) stimulation pulses, 25 ms apart, were delivered
ten times, responses were averaged and the PPR was calculated by dividing the peak current gener-
ated by the second pulse by the peak current generated by the first pulse.
Responses were recorded using an Axopatch 200B amplifier with pClamp 9 (Axon Instruments)
and Axoscope 9 (Axon Instruments) software. The majority of membrane currents were filtered at 5–
10 kHz, except for spontaneous synaptic currents, which were filtered at 1 kHz. The sampling rate
was always at least three times the filtering frequency.
Data were analyzed off-line using Clampfit 9 (Axon Instruments). Membrane resistance and capac-
itance were estimated by fitting the transient current elicited by a 5 mV voltage step to a single
exponential. Series resistance was monitored and was typically 10–20 MW. Cells were excluded from
the analysis when the resistance changed by >50% during the recording and/or was >30 MW (unless
otherwise stated). The amplitude of voltage-gated Na+ currents was calculated by subtracting the
passive components of current responses evoked by voltage steps. In particular, the current
response to a 20 mV hyperpolarizing voltage step with no active components, comprising the
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capacitive current and an ohmic leak conductance (which are proportional to the size of the voltage
step) was linearly scaled according to the size of the voltage step applied. This linearly scaled passive
component was then subtracted from all of the voltage-gated Na+ current responses evoked by
depolarizing voltage steps.
For detection of RR-evoked EPSCs, traces were high pass filtered at 2 Hz to eliminate drift in the
baseline over time. The events were automatically detected using a threshold search with the follow-
ing criteria: amplitude threshold set at three times the s.d. of the noise in regions of the trace lacking
obvious EPSCs, minimum event duration set to 1 ms and rising phase faster than the decay. The
detected events were then either accepted or rejected by the experimenter. The frequency was cal-
culated for each minute of drug application. For the majority of cells, the maximum frequency was
reached after 3 min of RR application. Therefore, the frequency of the events recorded between 3
and 6 min after application of the drug was used for comparison between Gria3null2–/– and control
mice. Event frequency during GYKI application was estimated over the last 3 min of drug
application.
To quantify kainate-evoked currents, the peak kainate-evoked current was measured at a nominal
holding potential of –63 mV. Kainate-evoked current magnitudes were then corrected after the
experiment for voltage errors generated by series resistance, using the value of Rs, a reversal poten-
tial of 0 mV and the current flowing before and after applying kainate. All cells, irrespective of their
series resistance, were included in this analysis.
Numbers of cells analyzed are indicated in the main text. For most experiments, cells from more
than three mice of a given genotype were analysed, apart from the PPR experiment (Figure 6F), the
Gria3null2+/+ group in the experiments of Figure 5B,C and the experiments in Figure 9 where two
animals were used. Only one cell was recorded from in each slice, so the numbers of cells given are
also the numbers of slices.
Internode measurements of dye-filled OLs
Coronal slices (225 mm thick) of P13-P15 mouse forebrain were prepared as described above (section
on Electrophysiology). The slices were superfused with bicarbonate-buffered solution containing 124
mM NaCl, 2.5 mM KCl, 26 mM NaHCO3, 1 mM NaH2PO4, 2 CaCl2, 1 mM MgCl2, 10 mM glucose,
pH 7.14, bubbled with a 95% O2/5% CO2 mixture. Mature OLs in the corpus callosum were identi-
fied by their location and morphology as revealed by expression of YFP. The cells were whole-cell
voltage clamped at –75 mV for 8 min to allow dye to enter the internodes fully. The pipettes had a
series resistance of 8–35 MW and the internal solution was 145 mM CsCl, 10 mM HEPES, 4 mM
MgATP, 2.5 mM NaCl, 1 mM EGTA and 0.5 mM Alexa Fluor 594, adjusted to pH 7.4 with CsOH.
After dye filling, the slices were immediately fixed in 4% PFA for 1–4 hr, washed three times in PBS,
mounted on slides under coverslips and imaged in a Zeiss LSM700 confocal microscope. Confocal
stacks (between 17 and 80 images separated by 1 mm steps) were made of each OL and internode
lengths were measured in three dimensions using the Fiji (ImageJ) simple neurite tracer.
In vivo EdU labelling
5’-ethynyl-2’-deoxyuridine (EdU, Invitrogen, 5 mg/ml in phosphate-buffered saline) was administered
to P3 mice by a single 30 ml subcutaneous injection (in the scruff of the neck) and the mice were per-
fused 4 hr later. P7 mice were injected subcutaneously twice with 60 ml of EdU solution, 3 hr apart,
and perfused 3 hr after the second injection. EdU was administered to P14 mice by intra-peritoneal
injection (5 mg per kg body weight) 3 times at 2.5 hr intervals and the mice were perfused 2.5 hr
after the final injection. EdU was provided to P70 mice via their drinking water (0.2 mg/ml EdU) with
free access for 6 days. These regimens were chosen in an attempt to label a comparable proportion
of OPs at each age, given that the cell cycle time is known to increase from less than a day to >10
days over this age range (Rivers et al., 2008; Psachoulia et al., 2009; Young et al., 2013).
Tissue processing
Mice were intracardially perfusion-fixed with 4% (w/v) paraformaldehyde (PFA; Sigma) in PBS.
Brain tissue was dissected and post- fixed in 4% PFA overnight at 4˚C. Tissue was cryoprotected
in diethylpyrocarbonate (DEPC)-treated 20% (w/v) sucrose (Sigma) for 24–48 hr in PBS. It was
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then frozen in Optimal Cutting Temperature (OCT) medium (Tissue Tek) on the surface of dry ice
and stored at –80˚C until needed.
In situ hybridization (ISH)
ISH was as described at http://www.ucl.ac.uk/~ucbzwdr/In%20Situ%20Protocol.pdf and by
Jolly et al. (2016). Briefly, coronal brain slices 20 mm thick were collected and incubated with digoxi-
genin (DIG)- and/or fluorescein (FITC)-labelled RNA probes. For single probe ISH, the DIG signal
was visualized with alkaline phosphatase (AP)-conjugated anti-DIG Fab fragment and either a mix-
ture of nitroblue tetrazolium (NBT, Roche) and 5-bromo-4-chloro-3-indolyl phosphate (toluidine salt)
(BCIP, Roche) for chromogenic reaction or Fast Red fluorescence system (Roche). For double ISH,
two probes – one FITC- and the other DIG-labelled – were applied simultaneously. For Gria (DIG)/
Pdgfra (FITC) probe combinations, the DIG-labelled probe was detected first using Fast Red, fol-
lowed by detection of FITC-labelled probe with horseradish peroxidase (POD)-conjugated anti-FITC
Fab Fragments (Roche) and tyramide signal amplification system (Perkin Elmer), according to the
manufacturer’s instructions. For Gria (DIG)/ Enpp6 (FITC) probe combinations, DIG- and FITC-
labelled probes were detected with POD-conjugated anti-DIG and anti-FITC Fab fragments, fol-
lowed by tyramide signal amplification. FITC and Cyanine3 (Perkin Elmer) were used for anti-FITC-
POD and anti-DIG-POD antibodies, respectively. After ISH, immunohistochemistry was performed as
described below. The plasmids (IMAGE clones) used to generate RNA probes were: clone 6842391
(Gria1), 6494013 (Gria2), 30668476 (Gria3), 6409918 (Gria4) and 4237600 (Enpp6).
Immunohistochemistry
Free-floating coronal sections (25 mm) were permeabilized/ blocked in a solution containing
10% (v/v) sheep, cow or donkey serum in 0.1% (v/v) Triton X-100 in PBS for 1–2 hr at 20–25˚C.
Sections were subsequently incubated in primary antibody diluted in blocking solution at 4˚C over-
night, washed in PBS and incubated with secondary antibody diluted in blocking solution contain-
ing Hoechst 33258 dye (Sigma, 1:1000) for 1–4 hr at 20–25˚C. Primary antibodies were anti-Pdgfra
(rabbit, New England Biolabs, 1:500 dilution), anti-GFP (chicken, Avas, 1:500 or rat, Fine Chemical
Products Ltd., 1:3000), anti-APC (clone CC1; mouse, Calbiochem,1:200), anti-Olig2 (rabbit, Chemi-
con, 1:700), anti-human-Olig2 (goat, R and D, 1:100), anti-Sox10 (guinea pig, 1:2000; a gift from
M. Wegner, University of Erlangen, Germany), anti-Ki67 (mouse, BD Biosciences, 1:1000), anti-
NeuN (rabbit, Chemicon, 1:500) and anti-cleaved Caspase-3 (rabbit, Abcam, 1:200). Secondary
antibodies (raised in donkey or goat) were Alexa Fluor 488-, 568-, 647-, or Cy3-conjugated sec-
ondary antibodies to rabbit, mouse, chicken, rat, human or guinea pig (Invitrogen,1:500–1000).
EdU detection was performed immediately after immunohistochemistry using the AlexaFluor-555
Click-iT detection kit (Invitrogen).
Image acquisition and analysis
Images were captured with either a light microscope (Zeiss Axioplan) with a Hamamatsu digital cam-
era (10x or 20x objective) or with a laser scanning confocal microscope (Leica TCS SPE; 20x objec-
tive), using standard excitation and emission filters for Hoechst 33258 and Alexa fluorophores.
Confocal Z-stacks were captured for each section with 1.5 mm steps.
Cells were counted in images of non-overlapping confocal sections of corpus callosum (3–4 fields
covering the entire length between the dorsolateral corners of the lateral ventricles at bregma 0–1
mm) or motor cortex (3–4 fields covering all cortical layers in at least three sections per mouse; num-
bers of mice are indicated in Results). Images were displayed on-screen in Adobe Photoshop and
cells were marked as they were counted, to avoid double-counting. All experiments were counted
with the experimenter blinded as to genotype.
Electron microscopy
Mice were perfused at UCL with PBS followed by 2.5% (v/v) glutaraldehyde and 2% (w/v) paraformal-
dehyde in 0.1 M cacodylate buffer (pH 7.4). Brains were removed into the same fixative, kept at 4˚C
for 48 hr, washed with 0.1 M cacodylate buffer then rinsed briefly with distilled water and shipped to
Japan in PBS at ambient temperature. Sagitally-sectioned brains were processed for electron micros-
copy (EM). After immersion in a 1% (w/v) osmium tetroxide solution for 2 hr at 4˚C, the specimens
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were dehydrated through a graded alcohol series and embedded in Epon 812 (TAAB Laboratories,
UK). The required area was trimmed and ultrathin sections were cut, collected on a platinum-coated
glass slide, stained with uranyl acetate and lead citrate and imaged in a scanning electron micro-
scope equipped with a back-scattered electron beam detector (Hitachi SU8010) at 1.5 kV accelerat-
ing voltage. EM images of sagittal sections of corpus callosum were taken at 2000x or 4000x
magnification at P14, and 15000x at P70 starting 100 mm posterior to the anterior-most edge of the
corpus callosum and spanning its entire dorso-ventral width, resulting in tiled images ~ 210 mm x
160 mm for P14 and ~25 mm x 170 mm for P70. Numbers of cross-sectional views of myelinated axons
were counted in one such image per animal (~2000 axons counted in each image, n = 5 mice per
genotype at P14 and >5000 axons counted in each image, n = 3 or four mice per genotype at P70).
To estimate g-ratios, the circumference of the axon as well as the external circumference of the mye-
lin sheath were measured using ImageJ, avoiding paranodal areas. The diameters of axon and mye-
lin sheath were calculated from these circumferential measurements, assuming a circular profile, and
the g-ratio was calculated. 50–100 axons were counted in each of 4 mice per genotype.
Statistics
Prism 6.0 (GraphPad) was used for statistical analysis. Data are presented as mean ± s.e.m. The Sha-
piro-Wilk test was used to test for normality of data distribution and p-values were determined using
a two-tailed Student’s t-test (when the distribution was consistent with normality) or non-parametric
Mann-Whitney U test, as appropriate. One-way ANOVA with Bonferroni post-hoc test or Kruskal-
Wallis with Dunn post hoc test were used for comparing multiple groups, as appropriate. When mul-
tiple t-tests or Mann-Whitney tests were performed, p-values were corrected for multiple compari-
son using a procedure equivalent to the Holm–Bonferroni method (for N comparisons, the most
significant P value is multiplied by N, the second most significant by (N   1), the third most signifi-
cant by (N   2), etc.; corrected p-values<0.05 are considered significant). Numbers of animals and
cells studied are stated for each experiment in the text.
We analyzed the Caspase-3 immunolabelling data as follows. First, we calculated for control con-
ditions the average fraction of Olig2+ cells that also expressed cleaved Caspase-3 (and hence were
undergoing apoptosis), by averaging across control litters (these numbers are stated in the main
text). Second, within each litter we normalized the data from experimental mice (double- or triple-
knockouts) and their Gria3null controls to the average of the controls in that same litter, setting the
latter to 1. Then we averaged these normalized data across all litters to obtain the mean percentage
increase in the fraction of Olig2+ cells that were apoptotic in experimental mice compared to control
mice.
We did not perform a priori power analyses to calculate the sample size for the experiments,
because the size of the effects expected was unknown before doing the experiments. We did how-
ever perform sample size calculation post hoc for experiments where group differences were close
to significant, using the observed mean ± s.d. of the control group, an effect size of 20–25%, a
power of 80% and p-value<0.05. With n = 3 for both groups, we should be able to detect a differ-
ence of ~23% in CC1+ OLs in Gria2–/– (Figure 4H). With n = 9 for control and n = 7 for the knockout
group we should be able to detect a ~20% reduction in CC1+ OLs in P21 Gria3null2–/– (Figure 7B).
With n = 14 for both groups, we should be able to detect a difference of ~20% in P14 Pdgfra+ OPs
in Gria3null2–/– (Figure 7F).
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